| 2026-06-11 | Dr. Nicholas A.J. BotwoodHead of Research & Development and Chief Medical Officer | -11,77k | 211,77k | Automatic Disposition | 18,00 | 60,89k | -16,19% |
| 2026-06-11 | Dr. Nicholas A.J. BotwoodHead of Research & Development and Chief Medical Officer | -53,75k | 229,05k | Derivative Exercise and Sale | 13,82 - 18,14 | 60,89k | - |
| 2026-06-01 | Mr. Michael A. MetzgerCEO & Director | -6,85k | 130,02k | Verkauf | 18,99 | 63,16k | -9,78% |
| 2026-06-01 | Mr. Keith Alan GoldanCFO, Treasurer & Principal Accounting Officer | -1,18k | 22,35k | Verkauf | 18,99 | 27,90k | -4,05% |
| 2026-02-09 | Mr. Keith Alan GoldanCFO, Treasurer & Principal Accounting Officer | -3,41k | 71,71k | Verkauf | 21,03 | 29,08k | -10,50% |
| 2026-02-09 | Mr. Michael A. MetzgerCEO & Director | -17,16k | 360,82k | Verkauf | 21,03 | 70,01k | -19,69% |
| 2026-02-06 | Mr. Michael A. MetzgerCEO & Director | -7,41k | 152,84k | Verkauf | 20,62 | 87,17k | -7,84% |
| 2026-02-06 | Mr. Keith Alan GoldanCFO, Treasurer & Principal Accounting Officer | -2,08k | 42,93k | Verkauf | 20,62 | 20,82k | -9,09% |
| 2025-12-01 | Mr. Keith Alan GoldanCFO, Treasurer & Principal Accounting Officer | -1,22k | 0,00 | Other Disposition | - | 15,52k | -7,31% |
| 2025-09-08 | Mr. Michael A. MetzgerCEO & Director | -157,31k | 867,38k | Derivative Exercise and Sale | 10,90 - 16,41 | 38,66k | - |
| 2025-08-14 | Mr. Dennis G. PodlesakIndependent Chairman | -57,60k | 460,38k | Derivative Exercise and Sale | 7,20 - 15,84 | 14,43k | - |
| 2025-07-16 | Mr. Michael A. MetzgerCEO & Director | -7,53k | 69,95k | Verkauf | 9,29 | 38,66k | -16,31% |
| 2025-07-16 | Mr. Keith Alan GoldanCFO, Treasurer & Principal Accounting Officer | -1,30k | 12,03k | Verkauf | 9,29 | 15,52k | -7,71% |